Back to News
Market Impact: 0.24
ARPA-H Selects UpDoc to Lead Development of Autonomous Clinical AI System, in an Initiative Joined by Microsoft, OpenAI and NVIDIA
Source: PR Newswire
Artificial IntelligenceHealthcare & BiotechTechnology & InnovationRegulation & Legislation
UpDoc was awarded up to $9.2 million through ARPA-H's ADVOCATE program to develop and validate an autonomous clinical AI system, initially focused on cardiovascular disease. The funding supports future FDA authorization and real-world deployment, representing a positive validation for the company's healthcare AI technology but with limited broad market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
More News
- Here’s the ‘core economic flaw’ in the AI bull case as stock and bond trades unravel, according to a top economist
- 5 big analyst AI moves: ’Uniquely catalyst-rich’ months ahead for SpaceX
- Brookfield to open Qatar office as it expands Middle East operations
- Xencor reports phase 1 data for cancer drug XmAb819
- The experience economy keeps defying expectations. Maybe we’ve been looking at it all wrong
- The U.S. military and NASA have power problems. Nuclear microreactors might solve both